We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAGR.L Regulatory News (BAGR)

  • There is currently no data for BAGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

25 Sep 2015 07:00

RNS Number : 1673A
Bagir Group Ltd
25 September 2015
 

25 September 2015

 

Bagir Group Ltd.

("Bagir" or the "Company")

 

Interim Results

for the six months ended 30 June 2015

 

Bagir (AIM: BAGR), a designer, creator and provider of innovative formalwear tailoring, announces its results for the six months ended 30 June 2015.

 

 

HIGHLIGHTS

 

· Revenue of $45.5m (H1 2014: $48.0m)

· Adjusted EBITDA of $(0.2)m* (H1 2014 :$1.7m)

· Operating (loss) income of $(1.9)m (H1 2014: $0.0m)

· Adjusted operating (loss) income of $(0.4)m** (H1 2014: $1.5m)

· Adjusted profit (loss) before tax of $(1.7)m** (H1 2014: $(0.9)m)

· Net debt at 30 June 2015 of $8.2m (31 Dec 2014: $12.5m)

· Competitive pressures and the deferral of sales planned for 2015 into 2016 are expected to result in a significantly worse second half trading performance

· Recovery Plan extended to focus core activities on higher value added products with better returns, and with other products supplied from the Ethiopia facility as it is developed; it will also include further significant reductions in overhead costs

· Actions being taken to restructure the Board on a more appropriate basis, with reduced costs

* Adjusted for depreciation of $0.2m, amortization of intangibles of $1.2m and non-recurring Recovery Plan consultancy cost of $0.2m

** Adjusted for amortization of intangibles of $1.2m and non-recurring Recovery Plan consultancy costs of $0.2m

 

 

Danny Taragan, CEO of Bagir, said:

 

"Despite the reduction in sales from our previous largest customer, as announced in May 2014, good progress has been made in broadening the Company's activities. The development of the Ethiopia facility is progressing well and this represents an attractive opportunity and source of increased competitive advantage.

 

"We will be extending our Recovery Plan to focus our core businesses on higher value added activities with better returns, enabling us to continue to materially improve cost efficiency."

 

 

For further information, please contact:

 

Bagir Group Ltd.

Danny Taragan, Chief Executive Officer

Udi Cohen, Chief Financial Officer

 

via FTI Consulting

N+1 Singer

Nic Hellyer

Alex Wright

James Maxwell

 

+44 (0) 20 7496 3000

FTI Consulting

Alex Beagley / Tom Hufton

+44 (0) 20 3727 1000

 

 

 

STRATEGIC AND FINANCIAL REVIEW

 

Despite the loss of a substantial proportion of revenue from its previous largest customer, as announced in May 2014, the Company has successfully grown revenue elsewhere during the six months to 30 June 2015, through additional sales to other existing and new retail customers.

 

Following a review of its business strategy and operating processes, the Company commenced a Recovery Plan (the "Plan") to improve the effectiveness of its processes and reduce costs. As part of the Plan, the Company decided to upgrade its IT systems and implementation of this has progressed well in the first half.

 

The Company expects the second half of the year to be more difficult than the first half, due to competitive pressures and the deferral of sales planned for 2015 into 2016. In light of this, the Company has decided to extend the scope of the Plan to focus core activities on higher value added products, with better returns, and with other products supplied from the Ethiopia facility as it is developed; it will also include further significant reductions in overhead costs.

 

The development of the production facility in Ethiopia, which was purchased in November 2014, is progressing to plan and the first production line of trousers for export is expected to be undertaken during the fourth quarter of 2015. The facility is expected to give Bagir a strong competitive advantage due to its duty free exports status for sales to the EU and US, its competitive production costs and government support for the textile industry. It is also intended that other products will progressively be provided by the facility as its capacity and expertise develops.

 

Revenue

Revenue for the six months ended 30 June 2015 was $45.5m compared with $48.0m for the first half of 2014. The reduction in revenue compared with the comparable period last year was mainly due to the decline in sales to the Company's former largest customer as announced last year. The Company has however successfully grown revenue elsewhere through additional sales to other existing and new retail customers.

 

Gross margin

The gross margin for the six months ended 30 June 2015 was 14.5% compared with 17.4% for the first half of 2014. This decline was also predominantly due to the reduction in higher margin sales to the Company's former largest customer and the impact of the devaluation of the pound\dollar exchange rate, which reduced gross profit by approximately $0.4m.

 

Operating expenses

Selling and marketing expenses increased to $5.0m in H1 2015 (H1 2014: $4.2m), mainly due to approximately $1.0m additional variable selling costs associated with different product mix and an increased level of smaller purchase orders. Other costs decreased as a result of the Plan.

 

The development costs decreased to $1.2m in H1 2015 (H1 2014: $1.8m) as a result of the Plan.

 

The general and administrative expenses increased to $2.2m in H1 2015 (H1 2014: $2.0m), due mainly to expenses arising from the Company's listing and $0.2m one-off consultancy costs associated with the implementation of the Plan. Other costs decreased.

 

Adjusted EBITDA

Adjusted EBITDA (before non-recurring recovery plan consultancy costs) for the six months ended 30 June 2015 was $(0.2)m (H1 2014: $1.7m).

 

Adjusted operating income and profit (loss) before taxation

Adjusted operating income (loss) and profit (loss) before tax (before $1.2m amortization of intangible assets and before $0.2m non-recurring Plan consultancy costs) for the six months ended 30 June 2015 was $(0.4)m and $(1.7)m respectively, compared with $1.5m and $(0.9)m respectively in the first half of 2014. The reduction in profit compared with the comparable period last year is due to the decline in sales to the Company's previous largest customer.

 

Loss per share

Basic and fully diluted earnings (loss) per share for the period was $(0.06) (H1 2014: $(0.10)).

 

Net debt

As at 30 June 2015, net debt decreased to $8.2m compared with $12.5m at 31 December 2014 and $8.5m at 30 June 2014. Net debt reduced mainly due to changes associated with the Company's working capital and approximately $2m increase in invoice financing.

 

The Company's financial covenants were reset with the Company's banks in January 2015 for the years 2015 and 2016 and the Company made an early repayment of $2.3m of long term loans in January 2015 that were originally scheduled for payment in monthly payments during 2015 and the first quarter of 2016.

 

As of 30 June 2015, the Company is complying with the financial covenants.

 

Cash and cash equivalents

As at 30 June 2015, cash and cash equivalents were $13.3m compared with $11.4m at 31 December 2014 and $16.1m at 30 June 2014.

 

OUTLOOK

 

The Company has made good progress in developing revenues to replace its previous largest customer during the six months to 30 June 2015. However, as noted above, the Company expects the second half of the year to be more difficult than the first half due to competitive pressures and the deferral of sales planned for 2015 into 2016. As a result, the Company expects trading for the second half of the current financial year to be significantly worse than the first half.

 

The refocusing of activities as part of the extension to the Plan is planned to result in a sustainable trading performance in 2016 with continuing improvement in subsequent years.

 

BOARD RESTRUCTURING AND BOARD COSTS

 

In light of the Company's current trading, the Directors of the Company have concluded that the Board should be restructured on a more appropriate basis, with significantly reduced costs. To achieve this:

 

Keith Hamill (Non-Executive Chairman) and George Adams (Independent Non-Executive Director) have decided to step down as of 30 September 2015, waiving notice entitlements under their appointment agreements.

 

Tessa Laws, who is currently an Independent Non-Executive Director, will become Non-Executive Chairman.

 

The Board will propose a shareholder resolution (in accordance with Israeli law) to appoint Donald Stewart (former Chairman of the Quoted Companies Alliance) as a new Independent Non-Executive Director in due course.

 

All remaining Non-Executive Directors have agreed to a 33% reduction in their fees from 1 October 2015, to be reviewed as at 31 December 2016.

 

 

 

 

BAGIR GROUP LTD.

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF 30 JUNE 2015

UNAUDITED

IN U.S. DOLLARS IN THOUSANDS

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

 

 

30 June

 

31 December

 

 

Unaudited

 

Audited

 

 

2015

 

2014

 

2014

 

 

U.S. dollars in thousands

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

Cash and cash equivalents

 

13,332

 

16,142

 

11,420

Short-term investments

 

512

 

434

 

397

Trade receivables

 

8,441

 

10,586

 

10,247

Other receivables

 

2,078

 

3,235

 

3,017

Inventories

 

8,794

 

7,910

 

10,379

 

 

 

 

 

 

 

 

 

33,157

 

38,307

 

35,460

 

 

 

 

 

 

 

NON-CURRENT ASSETS:

 

 

 

 

 

 

Investment in a joint venture

 

1,747

 

-

 

1,765

Property, plant and equipment

 

1,150

 

1,473

 

1,308

Goodwill

 

5,689

 

5,689

 

5,689

Other intangible assets

 

4,178

 

6,073

 

4,968

Deferred taxes

 

362

 

450

 

372

 

 

 

 

 

 

 

 

 

13,126

 

13,685

 

14,102

 

 

 

 

 

 

 

 

 

46,283

 

51,992

 

49,562

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

 

 

30 June

 

31 December

 

 

Unaudited

 

Audited

 

 

2015

 

2014

 

2014

 

 

U.S. dollars in thousands

 LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

Credit from banks and current maturities of long-term loans

 

11,295

 

11,500

 

11,880

Trade payables

 

7,179

 

7,383

 

7,351

Other payables

 

8,086

 

6,079

 

5,597

 

 

 

 

 

 

 

 

 

26,560

 

24,962

 

24,828

NON-CURRENT LIABILITIES:

 

 

 

 

 

 

Loans from banks

 

10,192

 

13,115

 

12,025

Employee benefit liabilities

 

427

 

520

 

456

Obligation relating to lease agreement

 

156

 

430

 

155

Deferred taxes

 

92

 

140

 

116

 

 

 

 

 

 

 

 

 

10,867

 

14,205

 

12,752

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:

 

 

 

 

 

 

Share capital

 

574

 

574

 

574

Share premium

 

78,322

 

78,449

 

78,322

Capital reserve for share-based payment transactions

 

1,449

 

1,428

 

1,444

Capital reserve for transactions with shareholders

 

10,165

 

10,165

 

10,165

Adjustments arising from translation of foreign operations

 

(8,895)

 

(8,964)

 

(8,895)

Accumulated deficit

 

(74,705)

 

(70,773)

 

(71,574)

 

 

 

 

 

 

 

 

 

6,910

 

10,879

 

10,036

Non-controlling interests

 

1,946

 

1,946

 

1,946

 

 

 

 

 

 

 

Total equity

 

8,856

 

12,825

 

11,982

 

 

 

 

 

 

 

 

 

46,283

 

51,992

 

49,562

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

 

 

 

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND

OTHER COMPREHENSIVE INCOME

 

 

 

Six months ended

30 June

 

Year ended

31 December

 

 

Unaudited

 

Audited

 

 

2015

 

2014

 

2014

 

 

U.S. dollars in thousands

 

 

 

 

 

 

 

Revenues from sales

 

45,474

 

48,023

 

96,982

Cost of sales

 

38,860

 

(*39,659

 

80,075

 

 

 

 

 

 

 

Gross profit

 

6,614

 

8,364

 

16,907

 

 

 

 

 

 

 

Selling and marketing expenses

 

5,045

 

4,226

 

8,693

General and administrative expenses

 

2,249

 

2,024

 

4,321

Development costs

 

1,176

 

(*1,829

 

3,198

Expenses in connection with IPO

 

-

 

301

 

301

Other expenses (income), net

 

21

 

(12)

 

(121)

 

 

 

 

 

 

 

Operating income (loss)

 

(1,877)

 

(4)

 

515

 

 

 

 

 

 

 

Finance income

 

167

 

-

 

6

Finance expenses

 

(1,424)

 

(1,802)

 

(3,164)

Finance expenses relating to liabilities to shareholders

 

-

 

(562)

 

(562)

Company's share of losses of a joint venture

 

(18)

 

-

 

(12)

 

 

 

 

 

 

 

Loss before taxes on income

 

(3,152)

 

(2,368)

 

(3,217)

Tax benefit

 

(21)

 

(23)

 

(39)

 

 

 

 

 

 

 

Loss

 

(3,131)

 

(2,345)

 

(3,178)

 

 

 

 

 

 

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

Items to be reclassified or that are reclassified to profit or loss when specific conditions are met:

 

 

 

 

 

 

 Adjustments arising from translation of foreign operations

 

-

 

147

 

216

 

 

 

 

 

 

 

Items not to be reclassified to profit or loss in subsequent periods:

 

 

 

 

 

 

Remeasurment gain on defined benefit plans

 

-

 

-

 

32

 

 

 

 

 

 

 

Total other comprehensive income (loss)

 

-

 

147

 

248

 

 

 

 

 

 

 

Total comprehensive loss

 

(3,131)

 

(2,198)

 

(2,930)

 

 

 

 

 

 

 

 Loss attributable to equity holders of the Company

 

(3,131)

 

(2,345)

 

(3,178)

 

 

 

 

 

 

 

 Total comprehensive loss attributable to equity holders of the Company

 

(3,131)

 

(2,198)

 

(2,930)

 

 

*) Reclassified.

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND

OTHER COMPREHENSIVE INCOME (Cont.)

 

 

 

Six months ended

30 June

 

Year ended

31 December

 

 

Unaudited

 

Audited

 

 

2015

 

2014

 

2014

 

 

U.S. dollars in thousands (except share and per share data)

 

 

 

 

 

 

 

Loss per share attributable to equity holders of the Company (in dollars)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss

 

(0.06)

 

(0.10)

 

(0.09)

Weighted average number of Ordinary shares for basic and diluted loss per share (in thousands)

 

50,223

 

22,749

 

36,486

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

 

 

 

Attributable to equity holders of the Company

 

 

 

 

 

 

Share

capital

 

Share premium

 

Capital reserve for share-based payment transactions

 

Capital reserve for transactions with shareholders

 

Adjustments arising from translation of foreign operations

 

Accumulated deficit

 

Total

 

Non-controlling interests

 

Total equity

 

 

Unaudited

 

 

U.S. dollars in thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2015

 

574

 

78,322

 

1,444

 

10,165

 

(8,895)

 

(71,574)

 

10,036

 

1,946

 

11,982

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total loss and comprehensive loss

 

-

 

-

 

-

 

-

 

-

 

(3,131)

 

(3,131)

 

-

 

(3,131)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of share-based payment

 

-

 

-

 

5

 

-

 

-

 

-

 

5

 

-

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 June 2015

 

574

 

78,322

 

1,449

 

10,165

 

(8,895)

 

(74,705)

 

6,910

 

1,946

 

8,856

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

 

 

Attributable to equity holders of the Company

 

 

 

 

 

 

Share

capital

 

Share premium

 

Capital reserve for share-based payment transactions

 

Capital reserve for transactions with shareholders

 

Adjustments arising from translation of foreign operations

 

Accumulated deficit

 

Total

 

Non-controlling interests

 

Total equity (deficiency)

 

 

Unaudited

 

 

U.S. dollars in thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2014

 

30

 

27,879

 

1,411

 

10,165

 

(9,111)

 

(68,428)

 

(38,054)

 

1,946

 

(36,108)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss

 

-

 

-

 

-

 

-

 

-

 

(2,345)

 

(2,345)

 

-

 

(2,345

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments arising from translation of foreign operations

 

-

 

-

 

-

 

-

 

147

 

-

 

147

 

-

 

147

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss

 

-

 

-

 

-

 

-

 

147

 

(2,345)

 

(2,198)

 

-

 

(2,198)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issue of share capital

 

412

 

29,392

 

-

 

-

 

-

 

-

 

29,804

 

-

 

29,804

Conversion of capital notes to shareholders and loans from shareholders into shares

 

132

 

21,178

 

-

 

-

 

-

 

-

 

21,310

 

-

 

21,310

Cost of share-based payment

 

-

 

-

 

17

 

-

 

-

 

-

 

17

 

-

 

17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 June 2014

 

574

 

78,449

 

1,428

 

10,165

 

(8,964)

 

(70,773)

 

10,879

 

1,946

 

12,825

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

 

 

Attributable to equity holders of the Company

 

 

 

 

 

 

Share

capital

 

Share premium

 

Capital reserve for share-based payment transactions

 

Capital reserve for transactions with shareholders

 

Adjustments arising from translation of foreign operations

 

Accumulated deficit

 

Total

 

Non-controlling interests

 

Total equity (deficiency)

 

 

Audited

 

 

U.S. dollars in thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2014

 

30

 

27,879

 

1,411

 

10,165

 

(9,111)

 

(68,428)

 

(38,054)

 

1,946

 

(36,108)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss

 

-

 

-

 

-

 

-

 

-

 

(3,178)

 

(3,178)

 

-

 

(3,178)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments arising from translation of foreign operations

 

-

 

-

 

-

 

-

 

216

 

-

 

216

 

-

 

216

Remeasurement gain on defined benefit plans

 

-

 

-

 

-

 

-

 

-

 

32

 

32

 

-

 

32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive income

 

-

 

-

 

-

 

-

 

216

 

32

 

248

 

-

 

248

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive income (loss)

 

-

 

-

 

-

 

-

 

216

 

(3,146)

 

(2,930)

 

-

 

(2,930)

Issue of share capital

 

412

 

29,265

 

-

 

-

 

-

 

-

 

29,677

 

-

 

29,677

Conversion of capital notes to shareholders and loans from shareholders into shares

 

132

 

21,178

 

-

 

-

 

-

 

-

 

21,310

 

-

 

21,310

Cost of share-based payment

 

-

 

-

 

33

 

-

 

-

 

-

 

33

 

-

 

33

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2014

 

574

 

78,322

 

1,444

 

10,165

 

(8,895)

 

(71,574)

 

10,036

 

1,946

 

11,982

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

Six months ended

30 June

 

Year ended

31 December

 

 

Unaudited

 

Audited

 

 

2015

 

2014

 

2014

 

 

U.S. dollars in thousands

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss

 

(3,131)

 

(2,345)

 

(3,178)

 

 

 

 

 

 

 

Adjustments to reconcile loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Company's share of losses of a joint venture

 

18

 

-

 

12

Depreciation and amortisation

 

1,451

 

1,398

 

2,829

Deferred taxes, net

 

(14)

 

12

 

66

Change in employee benefit liabilities

 

(29)

 

41

 

9

Cost of share-based payment

 

5

 

17

 

33

Finance expenses, net

 

840

 

1,313

 

1,776

Tax benefit, net

 

(7)

 

(35)

 

(105)

Other

 

-

 

193

 

476

 

 

 

 

 

 

 

 

 

2,264

 

2,939

 

5,096

Changes in asset and liability items:

 

 

 

 

 

 

 

 

 

 

 

 

 

Decrease (increase) in trade receivables

 

1,806

 

(2,402)

 

(2,155)

Decrease (increase) in other receivables

 

720

 

(1,190)

 

(801)

Decrease (increase) in inventories

 

1,585

 

(1,269)

 

(3,827)

Increase (decrease) in trade payables

 

(548)

 

501

 

520

Increase (decrease) in other payables

 

261

 

(3,479)

 

(3,815)

 

 

 

 

 

 

 

 

 

3,824

 

(7,839)

 

(10,078)

Cash paid (received) during the period for:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest paid

 

(531)

 

(826)

 

(1,439)

Interest received

 

-

 

17

 

23

Taxes paid

 

-

 

(264)

 

(264)

 

 

 

 

 

 

 

 

 

(531)

 

(1,073)

 

(1,680)

 

 

 

 

 

 

 

Net cash provided by (used in) operating activities

 

2,426

 

(8,318)

 

(9,840)

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

Six months ended

30 June

 

Year ended

31 December

 

 

Unaudited

 

Audited

 

 

2015

 

2014

 

2014

 

 

U.S. dollars in thousands

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in joint venture

 

-

 

-

 

(1,657)

Purchase of property, plant and equipment

 

(52)

 

(113)

 

(148)

Realisation (purchase) of short-term investments, net

 

(115)

 

166

 

203

Bank deposits, net

 

-

 

290

 

290

Additions to intangible assets

 

(75)

 

-

 

(150)

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

 

(242)

 

343

 

(1,462)

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Issue of shares, net of expenses

 

-

 

29,804

 

29,677

Receipt of loans from banks

 

-

 

3,000

 

3,000

Payment of long-term liabilities from banks

 

(2,418)

 

(10,204)

 

(10,797)

Decrease in short-term credit, net

 

-

 

(410)

 

(530)

Short-term advance from joint venture

 

708

 

-

 

-

Factored receivables

 

1,938

 

-

 

-

Repayment of liability for acquisition of subsidiary

 

(500)

 

(750)

 

(1,250)

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

(272)

 

21,440

 

20,100

 

 

 

 

 

 

 

Translation differences on balances of cash and cash equivalents of foreign operations

 

-

 

7

 

(48)

 

 

 

 

 

 

 

Increase in cash and cash equivalents

 

1,912

 

13,472

 

8,750

Cash and cash equivalents at the beginning of the period

 

11,420

 

2,670

 

2,670

 

 

 

 

 

 

 

Balance of cash and cash equivalents at the end of the period

 

13,332

 

16,142

 

11,420

 

Significant non-cash transactions:

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of capital notes to shareholders and loans from shareholders into shares

 

-

 

21,310

 

21,310

Payables for investment in joint venture

 

-

 

-

 

120

Purchase of intangible assets on credit

 

376

 

-

 

-

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

 

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1:- GENERAL

 

a. Company description:

 

Bagir Group Ltd. ("the Company") is registered in Israel. The Company and its subsidiaries ("the Group") specialise in the manufacturing and marketing of men's and women's tailored fashion. The Company's Headquarters are located in Kiryat Gat, Israel. The Group's products are manufactured by a subsidiary and subcontractors. The Group's products are marketed in Europe (mainly in the U.K.), the U.S. and in other countries. As for operating segments, see Note 4.

 

b. The interim condensed consolidated financial statements for the six months ended 30 June 2015 were approved for issue in accordance with a resolution of the Board of Directors on 24 September 2015.

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

 

a. Basis of preparation of the interim consolidated financial statements:

 

The interim condensed consolidated financial statements for the six months ended 30 June 2015 have been prepared in accordance with IAS 34, Interim Financial Reporting, as adopted by the European Union. The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Group's annual consolidated financial statements as at 31 December 2014.

 

The accounting policies applied in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group's consolidated annual financial statements for the year ended 31 December 2014. 

 

b. Fair value:

 

The fair value of cash and cash equivalents, short-term investments, trade and other receivables, bank deposits, credit and loans from banks and trade and other payables approximates their carrying amount.

  

 

 

NOTE 3:- SUPPLEMENTARY INFORMATION

 

a. In January 2015, the Company signed an amendment to the financing agreements with the banks in the framework of which the Company has undertaken as follows:

(1) The Company has undertaken to meet certain revised financial covenants regarding debt coverage ratio and minimum equity and tangible equity, and these covenants vary depending on whether Nazarath is consolidated.

 

(2) The Company also undertook to make an early repayment of $2.3 million in January 2015 of long-term loans (that were originally scheduled for payment in 2015 and in the first quarter of 2016) and an early repayment of $0.3 million in the fourth quarter of 2015 (that were originally scheduled for payment at the end of 2017).

 

 (3) Regarding its investment in the joint venture, Nazarath Garment Share Company ("Nazarath"):

 

- To inform the banks of any intention to obtain control of Nazarath and the effect of the consolidation of Nazarath on the Company's financial statements.

 

- To undertake that the Company's loans to Nazarath should not exceed $ 5 million.

 

- The Company's loans to Nazarath will be used to finance working capital and/or current investments rather than finance losses of Nazarath.

 

 

The early repayment of $2.3 million described in (2) above was made by the Company in January 2015.

 

As of 30 June 2015, the Company is complying with the financial covenants.

 

b. On 31 March 2015, the Company signed an agreement to acquire a computer IT system at a cost of approximately $ 600 thousands

 

c. Further to Note 5 to the annual consolidated financial statements as of 31 December 2014, on 1 July 2015, the Company extended the agreement with the Egyptian partner in the subsidiary in Egypt whereby the Company will continue to control and manage the subsidiary for an additional period of 7 years starting 1 July 2015, in consideration for a fixed annual payment of $ 800 thousands. Accordingly, the Company will continue to fully consolidate the financial statements of the Egyptian subsidiary.

 

 

 

NOTE 4:- OPERATING SEGMENTS

 

a. General:

 

The Group's activity is the manufacturing and marketing of men and women's tailored fashion (mainly men's).

 

The operating segments are identified on the basis of information that is reviewed by the chief operating decision maker ("CODM") to make decisions about resources to be allocated and assess its performance. The Group's products are primarily marketed to two geographical areas: Europe and the U.S. and, accordingly, the Company has two geographical segments. The Company's activities in Europe are concentrated primarily in the U.K.

 

b. Financial information on operating segments:

 

 

 

Europe (mainly

the U.K.)

 

U.S.

 

Other

 

Total

 

 

Unaudited

 

 

U.S. dollars in thousands

Six months ended 30 June 2015 :

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenues from external customers

 

22,858

 

20,821

 

1,795

 

45,474

 

 

 

 

 

 

 

 

 

Segment profit (loss)

 

(2,858)

 

654

 

327

 

(1,877)

 

 

 

 

 

 

 

 

 

Unallocated expenses, net

 

 

 

 

 

 

 

(18)

Finance expenses, net

 

 

 

 

 

 

 

(1,257)

 

 

 

 

 

 

 

 

 

Loss before tax benefit

 

 

 

 

 

 

 

(3,152)

 

 

 

Europe (mainly

the U.K.)

 

U.S.

 

Other

 

Total

 

 

Unaudited

 

 

U.S. dollars in thousands

Six months ended 30 June 2014 :

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenues from external customers

 

(*26,301

 

20,933

 

 (*789

 

48,023

 

 

 

 

 

 

 

 

 

Segment profit (loss)

 

 (*(631)

 

708

 

(*246

 

323

 

 

 

 

 

 

 

 

 

Unallocated expenses, net

 

 

 

 

 

 

 

(327)

Finance expenses, net

 

 

 

 

 

 

 

(2,364)

 

 

 

 

 

 

 

 

 

Loss before tax benefit

 

 

 

 

 

 

 

(2,368)

 

 

*) Reclassified.

 

 

Europe (mainly

the U.K.)

 

U.S.

 

Other

 

Total

 

 

Audited

 

 

U.S. dollars in thousands

Year ended 31 December 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenues from external customers

 

52,838

 

42,057

 

2,087

 

96,982

 

 

 

 

 

 

 

 

 

Segment profit (loss)

 

(784)

 

979

 

370

 

565

 

 

 

 

 

 

 

 

 

Unallocated expenses, net

 

 

 

 

 

 

 

(62)

Finance expense, net

 

 

 

 

 

 

 

(3,720)

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

 

 

 

 

(3,217)

 

 

 

 

 

 

 

 

 

- - - - - - - - - - - - - - - - -

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LIMPTMBMTBIA
Date   Source Headline
18th May 20205:30 pmRNSBagir Group
18th May 202012:10 pmRNSAppointment of Liquidator
22nd Apr 20207:00 amRNSAppointment of Court Trustees
14th Apr 20207:00 amRNSFinancial Update
3rd Apr 20207:30 amRNSSuspension - Bagir Group Ltd
3rd Apr 20207:30 amRNSFinancial Update
31st Mar 20207:00 amRNSHolding(s) in Company
25th Mar 202012:00 pmRNSCOVID-19 Update
23rd Mar 20209:03 amRNSHolding(s) in Company
17th Mar 20201:24 pmRNSHolding(s) in Company
16th Mar 20208:20 amRNSHolding(s) in Company
2nd Mar 202011:20 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSUpdate on status with Shandong Ruyi and 19 Trading
13th Feb 20208:18 amRNSResignation of Chairperson
21st Jan 20207:55 amRNSHolding(s) in Company
13th Dec 20192:06 pmRNSHolding(s) in Company
2nd Dec 201911:02 amRNSResult of AGM
29th Nov 20198:20 amRNSHolding(s) in Company
22nd Oct 20199:46 amRNSNotice of AGM
7th Oct 20199:17 amRNSHolding(s) in Company
3rd Oct 20194:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:29 pmRNSHolding(s) in Company
2nd Oct 20193:20 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSHalf-year Report
10th Sep 201911:30 amRNSHolding(s) in Company
10th Sep 201910:55 amRNSHolding(s) in Company
5th Sep 201910:35 amRNSHolding(s) in Company
23rd Aug 20193:08 pmRNSHolding(s) in Company
19th Aug 20193:48 pmRNSHolding(s) in Company
12th Aug 20193:49 pmRNSHolding(s) in Company
12th Aug 20198:49 amRNSHolding(s) in Company
28th Jun 20197:00 amRNSPosting of Annual Report
25th Jun 20197:00 amRNSDirectorate Change
19th Jun 20197:00 amRNSUpdate on Strategic Partnership and Trading
31st May 201911:05 amRNSSecond Price Monitoring Extn
31st May 201911:00 amRNSPrice Monitoring Extension
31st May 20197:00 amRNSUpdate on Strategic Partnership
28th May 20192:05 pmRNSSecond Price Monitoring Extn
28th May 20192:00 pmRNSPrice Monitoring Extension
20th May 20194:40 pmRNSSecond Price Monitoring Extn
20th May 20194:35 pmRNSPrice Monitoring Extension
13th May 20197:00 amRNSDirectorate Change
4th Apr 20197:00 amRNSFinal Results
22nd Mar 201912:01 pmRNSHolding(s) in Company
15th Feb 201910:38 amRNSHolding(s) in Company
13th Feb 20192:00 pmRNSPrice Monitoring Extension
13th Feb 20197:00 amRNSUpdate on strategic partnership
3rd Jan 20192:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.